Analysis Tools
mortality/aging
|
• average survival time of 11.9 +/- 3 days following tamoxifen treatment for 5 days
|
cardiovascular system
|
• increase in ventricular end diastolic volume after tamoxifen treatment
|
|
• profound decrease in myocardial contractility, as assessed by fractional shortening, after tamoxifen treatment
|
muscle
|
• profound decrease in myocardial contractility, as assessed by fractional shortening, after tamoxifen treatment
|
